Glow Lifetech Corp. (GLOW.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 25.71 Thousand CAD | -51.75% |
| 2022 | 2.29 Million CAD | -56.5% |
| 2021 | 5.27 Million CAD | 3338.66% |
| 2020 | 153.47 Thousand CAD | -16.03% |
| 2019 | 182.77 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 284.09 Thousand CAD | -6.12% |
| 2024 Q2 | 271.62 Thousand CAD | 7.03% |
| 2023 Q1 | 313.61 Thousand CAD | -64.53% |
| 2023 FY | 1.1 Million CAD | -51.75% |
| 2023 Q4 | 302.63 Thousand CAD | -19.92% |
| 2023 Q3 | 377.92 Thousand CAD | -4.38% |
| 2023 Q2 | 395.23 Thousand CAD | 26.02% |
| 2022 Q2 | 502.66 Thousand CAD | -19.48% |
| 2022 FY | 2.29 Million CAD | -56.5% |
| 2022 Q1 | 624.26 Thousand CAD | 20.95% |
| 2022 Q4 | 884.12 Thousand CAD | 210.47% |
| 2022 Q3 | 284.77 Thousand CAD | -43.35% |
| 2021 Q4 | 516.13 Thousand CAD | 12.71% |
| 2021 FY | 5.27 Million CAD | 3338.66% |
| 2021 Q1 | 3.13 Million CAD | 31584.66% |
| 2021 Q2 | 1.16 Million CAD | -62.74% |
| 2021 Q3 | 457.93 Thousand CAD | -60.8% |
| 2020 FY | 153.47 Thousand CAD | -16.03% |
| 2020 Q4 | -9958.00 CAD | -111.68% |
| 2020 Q3 | 85.27 Thousand CAD | 119.42% |
| 2020 Q2 | 38.86 Thousand CAD | -1.13% |
| 2020 Q1 | 39.3 Thousand CAD | -20.82% |
| 2019 Q4 | 49.63 Thousand CAD | 40.29% |
| 2019 Q2 | 76.16 Thousand CAD | 252.87% |
| 2019 Q3 | 35.38 Thousand CAD | -53.55% |
| 2019 Q1 | 21.58 Thousand CAD | 0.0% |
| 2019 FY | 182.77 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | 99.505% |
| Asep Medical Holdings Inc | 7.74 Million CAD | 99.668% |
| BetterLife Pharma Inc. | 3.24 Million CAD | 99.206% |
| BioVaxys Technology Corp. | 2.4 Million CAD | 98.93% |
| ChitogenX Inc. | 2.83 Million CAD | 99.091% |
| Rapid Dose Therapeutics Corp. | 4.2 Million CAD | 99.389% |
| Defence Therapeutics Inc. | 12.65 Million CAD | 99.797% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | 95.443% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | 99.494% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | 96.189% |
| Pharmala Biotech Holdings Inc. | 1.21 Million CAD | 97.887% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | 64.328% |
| MYND Life Sciences Inc. | 1.47 Million CAD | 98.256% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | 97.861% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | 99.155% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | 97.33% |
| Telescope Innovations Corp. | 6.35 Million CAD | 99.595% |